Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Before the markets even opened today, stocks were buoyed by news out of China that the Chinese government might finally be willing to step in and do something big to stimulate itseconomy. That news was joined by Bill Dudley, president of the New York Federal Reserve, stating that perhaps, just perhaps, he was a little too bullish on the U.S. economy late last year. Cramer said he cannot overstate how important the Fed's stance on the economy is to the outlook for the stock market.
But the positive news didn't stop there. Ford (F) delivered a strong quarter that called into question the notion that the U.S. has seen a peak in auto sales. Meanwhile, in the oil patch, Marathon Oil (MRO) was able to put to rest fears of its demise by completing a successful 145-million-share secondary offering. "Another wounded player saved," proclaimed Cramer.
Finally, there was Workday (WDAY) , the cloud-based software player that reported a phenomenal quarter, only to see shares fall in yesterday's session. But today, Workday soared higher by 18.6%, adding fuel to the entire growth stock sector.
Executive Decision: Niraj Shah
For his "Executive Decision" segment, Cramer sat down with Niraj Shah, co-founder and CEO of online home goods retailer Wayfair (W) , which reported a strong quarter but has since seen its stock give back much of the early gains.
Shah said it was a very strong quarter for Wayfair, with new orders up 67% and repeat orders up over 90%. He said Wayfair now employs 450 engineers and continues to keep technology at the core of everything it does.
Shah also commented on Wayfair's expansion into Europe, saying the company is taking a slow and steady approach, but ultimately sees Europe being as big a market as the U.S.
Wayfair is also expanding into the offline world, offering catalogs for the first time to repeat customers as an additional touch point to offer ideas and inspiration.
Cramer said Wayfair is performing far better than he would expect given the current economic environment.
How to Know It's Time to Sell
Cramer has only a handful of rock-solid trading principles that have stood the test of time, but one of them is that accounting irregularities always equal sell. Always.
For another example of that mantra, investors need only look at Valeant Pharmaceuticals (VRX) , a stock trading over $120 a share back in October but now trades at less than half that amount.
The Valeant scandal started off small, Cramer recalled, but investors who sold on the first reports of questionable accounting and distribution practices were the only ones who came away unscathed. Over the past few months, Valeant shares have been able to to muster a few small rallies, such as after news of a partnership with Walgreens Boots Alliance (WBA) in December, but those lifts were all short lived.
Shares only continue to drift still lower, Cramer noted. Hillary Clinton called the company out by name as one of the bad apples in the drug business that she intends to "stop." Cramer said his accounting mantra has never let him down, and Valeant won't be the last time it will save investors money.
Executive Decision: Kevin Sayer
In his second "Executive Decision" segment, Cramer sat down with Kevin Sayer, president and CEO of DexCom (DXCM) , the real-time glucose monitoring company that just posted strong earnings that included a 1-cent-a-share earnings beat on a 55% rise in revenue and strong guidance for 2016.
Sayer said DexCom's recent worldwide product launch was a big stretch for his company, but it executed the plan very well. DexCom's business grew by 55% last year and the company is excelling in both the U.S. and Europe.
When asked about Dexcom's products, Sayer noted that 98% of private insurance now covers constant glucose monitoring. Thanks to a partnership with Alphabet (GOOGL) , a stock Cramer owns for his charitable trust, Action Alerts PLUS, the cost of such devices will continue to decline. When it comes to glucose monitoring, Sayer said accuracy matters and DexCom has the most accurate products, which is why it doesn't fear the competition.
Cramer said DexCom is one of the good apples in the health care space and is saving patients and our health care system a lot of money.
In the Lightning Round, Cramer was bullish on PayPal (PYPL) , Service Corp (SCI) , CenturyLink (CTL) , Verizon (VZ) , Spirit Airlines (SAVE) , Delta Air Lines (DAL) , American Airlines (AAL) and Southwest Airlines (LUV) .
Executive Decision: Susan Salka
Salka said there continues to be a shortage of qualified doctors and nurses in our country and that trend only seems to be getting worse as many health care professionals are nearing retirement age. She said AMN clients are increasingly challenged to find staffing for both their temporary and permanent needs.
AMN is about a lot more than just placement, however. Salka noted that AMN continues to diversify its offerings to include on-boarding, training and other services as more and more facilities are not just looking for professionals, they're looking for leaders and innovators.
Salka added that for AMN, the economy is not the only factor driving the business. She said the aging population continues to be a big driver, as is the consolidation of the health care industry.
Cramer said the time is right for a stock like AMN.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.